TrialCancer chemotherapy and pharmacology2018

A phase I/II study of GLIF combination chemotherapy for taxane/platinum-refractory/resistant endometrial cancer (GOGO-EM2).

Yusuke Tanaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.